Physician

Adarsh Vijay, MD

According to 2025 Medicare claims, Adarsh Vijay, MD (NPI: 1205389996) practices general surgery in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is SOUTH BROWARD HOSPITAL DISTRICT (NPI: 1093262248; TIN: 596014973) and primary practice location at 33021-5421. Vijay is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535) and Imperium Clinical Partners (ACO ID: A4945), participating under the MSSP model.

Vijay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 66 traditional Medicare patients, billed 208 HCPCS/CPT codes, and received $40,446 in Medicare payments. The top billing code was 99232 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes). Part D data shows 410 prescription claims across 53 beneficiaries totaling $24,627 in drug costs, led by Valganciclovir Hcl (Valganciclovir Hcl). DME data shows 196 claims. Open Payments data shows 2 records totaling $157. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,371 to $24,627. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	19	55	$19,655
2019	80	236	$56,268
2020	95	291	$68,690
2021	122	427	$118,193
2022	139	352	$85,824
2023	60	316	$68,205
2024	66	208	$40,446

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	12	44	$3,371
2020	15	62	$2,044
2021	23	87	$3,229
2022	43	244	$24,590
2023	70	848	$82,065
2024	53	410	$24,627

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	32	$9,213
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	62	211	$18,110
2023	134	487	$23,144
2024	73	196	$7,009

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	28	126	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	23	23	$51

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Valganciclovir Hcl	Valganciclovir Hcl	56	1,680	$12,514
Tacrolimus	Tacrolimus	17	483	$3,518
Fluconazole	Fluconazole	46	1,440	$1,168
Famotidine	Famotidine	77	2,280	$534
Nystatin	Nystatin	16	480	$527

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	14	38	$3,309
J7507	Tacrolimus, immediate release, oral, 1 mg	N	14	30	$2,381
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	18	63	$803
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	14	28	$489
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	13	37	$27

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$157	SANOFI-AVENTIS U.S. LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adarsh Vijay, MD?

Tedicare shows public-source Medicare data for Adarsh Vijay, MD (NPI 1205389996), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adarsh Vijay, MD have ACO affiliation data?

Adarsh Vijay, MD is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535) and Imperium Clinical Partners (MSSP, ACO ID A4945).

What billing organization is linked to Adarsh Vijay, MD?

Adarsh Vijay, MD is linked to SOUTH BROWARD HOSPITAL DISTRICT (billing NPI 1093262248) in the available physician profile data.

Does Adarsh Vijay, MD have Open Payments data?

Adarsh Vijay, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.